Global Veterinary Infectious Diseases Diagnostics Market Size, Share, Opportunities, And Trends By Technology Type (Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Pathogen Type (Virus, Bacteria, Parasite), By Animal Type (Companion Animal (Cats, Dogs, Horse, Others), Livestock (Cattle, Swine, Sheep, Others)), By End-User (Diagnostics Laboratories, Veterinary Clinics, Research Centers), And By Geography - Forecasts From 2025 To 2030

Veterinary Infectious Diseases Diagnostics Market Size:

The Global Veterinary Infectious Diseases Diagnostics Market is expected to grow from USD 2.795 billion in 2025 to USD 4.124 billion in 2030, at a CAGR of 8.09%.

The prevalence of diseases such as colony collapse disorder, zoonotic diseases, rabies, and canine distemper (which is also called Hardpad disease), among some other diseases, is increasing due to the different types of bacteria, viruses, and parasites present in the surroundings and the lack of practice of proper hygiene among the animals. This leads to spreading infections and causes health-related problems for pets and livestock owners. Thus, this is encouraging them to go for regular veterinary infectious disease diagnostics checkups to keep the animal health in check and prevent them from contracting a disease, which is boosting the market growth.

Technology Launched by Major Market Players

The better, advanced, and diverse varieties of veterinary infectious disease diagnostics with enhanced features can effectively aid in the proper and efficient diagnosis and detection of diseases. These products are being launched, and products being offered by existing and new players in different markets are estimated to lead to increased adoption and propel the market growth further over the forecast period.

Some of the examples of the technology launches and animal types are as follows:

•  Zoetis, one of the leading companies dealing in the provision of animal health services ad diagnostics, announced that they had launched a new technology to expand their technology and services under their portfolio by releasing a technology called the “Stablelab.” It is a handheld device, a type of point-of-care diagnostic blood test that can provide veterinarians with critical information about equine inflammation within 10 minutes. The hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA), which is one of the major acute-phase proteins produced by the liver, and its early detection and diagnosis can help the veterinarians detect infectious diseases sooner and respond to the inflammation caused in the caused by the infection earlier even before the symptoms start.
• Zoetis announced that they had signed an agreement with Colorado State University (CSU) to facilitate the establishment of a research lab at CSU. In this lab, the livestock immune system and the target were tested to target new immunotherapies, which paved the way for other new and better alternatives to the antibiotics used in the food-producing animals. In addition, this Incubator Research Lab will operate at the Research Innovation Center on the foothills of CSU Campus starting in early 2020. Therefore, due to getting access to the ore laboratories, highly skilled scientists will give Zoetis the ability to better understand the immune system of the livestock to generate new candidates for accelerating the research and development activities further.
• Prosolit, one of the leading companies that are involved in the provision of diagnostic products and technologies for veterinary infectious disease testing, offers a technology called the “ELISA kit for serodiagnosis of Bovine Adenovirus3 “, which is a test designed for the diagnosis of this virus in the cattle. It is an indirect test for blood sera, plasma, and milk. It helps in faster, more effective, and more accurate testing and result declaration as it uses reliable technology and provides many testing kits.

Veterinary Infectious Diseases Diagnostics Market Segmentation Analysis:

• Molecular Diagnostics are estimated to increase their market share over the forecast period as the demand for faster and more effective results and the growing adoption among research centres and diagnostic laboratories.

Molecular diagnostics are a type of diagnostic test that is referred to as the detection of the genomic variants that facilitates the detection, diagnosis, sub-classification, and prognosis. It also includes monitoring the responses to therapy. Molecular diagnostics also include laboratory medicine. The technology used in genomics is increasingly essential for the provision of accurate diagnosis. Molecular diagnostics are estimated to increase their market share over the forecast period, which is attributable to the fact that infectious diseases are getting more complex and are growing increasingly common among livestock and companion animals, thus leading to rising concern among the owners. This encourages them to opt for better and more effective tests that can deliver efficient results in a short period.

• Livestock animals to increase their share over the forecast period

Livestock animals are one of the key drivers for sustainable development in agriculture apart from contributing to food security, nutrition, and the alleviation of poverty and economic growth. Out of every five farm animals, about one animal is lost to serious infectious diseases, which can lead to it affecting the individuals in the population globally as they depend on a daily supply of meat, poultry, milk, and other dairy products, the quality of which can deteriorate due to disease. In addition, the cost of the burden of diseases is increasing and can lead to losses of around US$80 billion.

The livestock animals are estimated to hold a notable share over the forecast period since there has been an increase in the number of farm animals suffering from different diseases as mostly the conditions, they are held in are unhygienic and not clean. This results in the growth of bacteria and parasites in water bodies and water bowls they drink, resulting in their feed getting ridden with parasites.  This is driving the requirement of diagnostics and veterinary services for these animals to prevent the risk of getting seriously ill by infections.

Segmentation:

• By Technology Type
  • Immunodiagnostics
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others
• By Pathogen Type
  • Virus
  • Bacteria
  • Parasite
  • Others
• By Animal Type
  • Companion Animal
    • Cats
    • Dogs
    • Horse
    • Others
  • Livestock
    • Cattle
    • Swine
    • Sheep
    • Others
• By End-User
  • Diagnostics Laboratories
  • Veterinary Clinics
  • Research Centers
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY TECHNOLOGY TYPE

5.1. Introduction

5.2. Immunodiagnostics

5.3. Molecular Diagnostics

5.4. Hematology

5.5. Urinalysis

5.6. Others

6. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY PATHOGEN TYPE 

6.1. Introduction

6.2. Virus

6.3. Bacteria

6.4. Parasite

6.5. Others 

7. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY ANIMAL TYPE

7.1. Introduction

7.2. Companion Animal

7.2.1. Cats

7.2.2. Dogs

7.2.3. Horse

7.2.4. Others

7.3. Livestock

7.3.1. Cattle

7.3.2. Swine

7.3.3. Sheep

7.3.4. Others

8. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY END-USER

8.1. Introduction

8.2. Diagnostics Laboratories

8.3. Veterinary Clinics

8.4. Research Centers

9. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Italy

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. Australia 

9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. BIOMÉRIEUX S.A. 

11.2. Chembio Diagnostics, Inc. 

11.3. Heska Corporation 

11.4. IDEXX Laboratories, Inc. 

11.5. INDICAL BIOSCIENCE GmbH 

11.6. Neogen Corporation 

11.7. QIAGEN N.V. 

11.8. Randox Laboratories Ltd. 

11.9. Thermo Fisher Scientific Inc. 

11.10. Virbac 

11.11. Zoetis Inc.

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

BIOMÉRIEUX S.A.

Chembio Diagnostics, Inc.

Heska Corporation

IDEXX Laboratories, Inc.

INDICAL BIOSCIENCE GmbH

Neogen Corporation

QIAGEN N.V.

Randox Laboratories Ltd.

Thermo Fisher Scientific Inc.

Virbac

Zoetis Inc.